We are here to help during COVID-19. We have video appointments available now. If you are a new patient, call (844) 867-8444 or you can click here to register.
Insurance accepted and some health plans are waiving copay fees during this time.

Providing Relief for Patients

According to the Centers for Disease Control (CDC), 14–17% of the adult population will experience a condition called Major Depressive Disorder (MDD), also known as “clinical depression,” during their lifetime. MDD is usually treated with talk therapy and/or medication; however, a key clinical study shows that over 40% of these patients might not respond to medication as they suffer from a condition called Treatment-Resistant Depression (TRD). These patients need to seek an alternative treatment for their symptoms.

Both Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray are alternative treatments for MDD that have been shown to be safe and effective for those with TRD.